HomeTCRX • NASDAQ
add
Tscan Therapeutics Inc
Previous close
$2.97
Day range
$2.92 - $3.10
Year range
$2.60 - $9.69
Market cap
170.08M USD
Avg Volume
401.16K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 1.05M | -73.01% |
Operating expense | 7.41M | 25.70% |
Net income | -29.89M | -29.96% |
Net profit margin | -2.85K | -381.56% |
Earnings per share | -0.25 | -4.17% |
EBITDA | -31.60M | -34.66% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 271.12M | 25.85% |
Total assets | 348.03M | 19.44% |
Total liabilities | 118.94M | -2.84% |
Total equity | 229.09M | — |
Shares outstanding | 53.37M | — |
Price to book | 0.69 | — |
Return on assets | -22.56% | — |
Return on capital | -24.50% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -29.89M | -29.96% |
Cash from operations | -27.92M | -448.24% |
Cash from investing | -82.35M | -34.09% |
Cash from financing | 1.23M | 588.10% |
Net change in cash | -109.04M | -103.25% |
Free cash flow | -19.78M | -250.80% |
About
Founded
2018
Headquarters
Website
Employees
188
